Remecure ApS: Financial statements 2022
CVR: 40259724
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Remecure ApS (CVR 40259724) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -30,765 and a net result of DKK -38,720 compared with DKK 17,026 the year before. Equity in the 2022 report amounted to DKK 8,546. The solvency ratio was 3.4%.
- Gross Profit
- DKK -30,765
- Profit/Loss
- DKK -38,720
- Equity
- DKK 8,546
- Total Assets
- DKK 253,178
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -31 t. | -39 t. | 9 t. | 0 |
| 2021 | - | 20 t. | 17 t. | 47 t. | 0 |
| 2020 | - | -295 | -554 | -10 t. | 0 |
| 2019 | - | -9 t. | -9 t. | -9 t. | - |
Official annual report
Keep an eye on Remecure ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Remecure ApS has published its annual report for 2021. Gross profit came to DKK 20,103, and the net result was DKK 17,026.
About Remecure ApS
Remecure ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Stephanie Cecilia Arnfeldt Castella and Mohamed MAMDOUH Takach. The company is owned by Stephanie Cecilia Arnfeldt Castella and Mohamed MAMDOUH Takach. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 8,950 and a net result of DKK 5,453 compared with DKK -17,659 the year before. Equity in the 2025 report amounted to DKK 234,891.